ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 10.82
+1.03 (10.52%)
Jul 17, 2025, 4:08 PM HKT
HKG:1541 Market Cap
HKG:1541 has a market cap or net worth of 3.99 billion as of July 17, 2025. Its market cap has decreased by -26.40% in one year.
Market Cap
3.99B
Enterprise Value
3.33B
Revenue
84.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.82
Market Cap Chart
Since September 5, 2023, HKG:1541's market cap has decreased from 7.29B to 3.99B, a decrease of -45.27%. That is a compound annual growth rate of -27.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2025 | 3.99B | 89.73% |
| Dec 31, 2024 | 2.10B | -81.21% |
| Dec 29, 2023 | 11.19B | 53.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 259.57B |
| Hansoh Pharmaceutical Group Company | 205.13B |
| Innovent Biologics | 147.35B |
| JD Health International | 146.09B |
| Sino Biopharmaceutical | 115.18B |
| WuXi Biologics | 115.16B |
| Akeso | 113.09B |
| CSPC Pharmaceutical Group | 98.87B |